-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Overweight on NICE, Lowers Price Target to $165

Benzinga·11/19/2025 13:52:25
Listen to the news
Barclays analyst Tavy Rosner maintains NICE (NASDAQ:NICE) with a Overweight and lowers the price target from $200 to $165.